Clinical Research Infrastructure in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Research Infrastructure in Brazil

Clinical Research Infrastructure in Brazil – CRO Brazil

Clinical research serves as a crucial driver of medical advancements, improving patient care and shaping healthcare policies. Brazil, a vibrant and diverse country with a robust healthcare system, has been making significant strides in developing a strong clinical research infrastructure.

With its large population, renowned research institutions, and evolving regulatory framework, Brazil has emerged as a key player in the global clinical research landscape. In this blog post, we will delve into the current state of clinical research infrastructure in Brazil, highlighting its key components, challenges, and the opportunities it presents for medical innovation.

Overview of Clinical Research Infrastructure

Brazil’s clinical research infrastructure comprises a vast network of research centers, universities, hospitals, and regulatory bodies. The Brazilian Health Regulatory Agency (ANVISA) plays a central role in ensuring the safety and efficacy of clinical trials. ANVISA regulates the approval and oversight of clinical trial protocols, aligning with international guidelines such as Good Clinical Practice (GCP).

Additionally, Brazil is home to prestigious research institutions and universities, fostering a rich academic environment for clinical research. These institutions collaborate with government entities, private organizations, and international partners to facilitate the planning, execution, and analysis of clinical trials.

Regulatory Framework and Ethical Considerations

Brazil has a well-established regulatory framework that governs clinical research. ANVISA, as the primary regulatory body, sets the guidelines for conducting clinical trials and ensures compliance with ethical considerations.

The Brazilian National Research Ethics Committee (CONEP) plays a vital role in evaluating the ethical aspects of research protocols involving human subjects, providing oversight and guidance.

Moreover, Brazil has adopted comprehensive regulations to protect research participants, ensuring their rights and well-being. The country has implemented rigorous procedures for informed consent, privacy protection, and data security, aligning with international ethical standards.

Clinical Research Infrastructure in Brazil

Clinical Research Infrastructure in Brazil

Clinical Research Infrastructure in Brazil

Advantages of Conducting Clinical Trials in Brazil

Brazil offers several advantages for conducting clinical trials. Firstly, its diverse population encompasses various ethnicities, genetic backgrounds, and disease prevalence, providing a broader representation of patients for research studies. This diversity enhances the generalizability of study findings and allows for more comprehensive data collection.

Secondly, Brazil’s healthcare system includes a mix of public and private institutions, offering a significant patient pool for recruitment. The country’s well-developed primary healthcare network enables access to a diverse range of potential trial participants across different regions.

Furthermore, Brazil’s relatively lower costs compared to developed nations make it an attractive destination for sponsors and researchers. The reduced expenses associated with patient recruitment, site management, and operational activities can lead to cost-effective clinical trials without compromising quality or compliance.

Challenges and Opportunities

Despite the progress made, Brazil faces challenges in fully optimizing its clinical research infrastructure. These challenges include bureaucratic processes for trial approvals, limited research funding, and the need to enhance public awareness about clinical trials and their benefits.

Addressing these challenges requires collaborative efforts among regulatory authorities, research institutions, and the private sector.

Brazil also presents numerous opportunities for further growth. Strengthening partnerships and collaborations between academia, industry, and government entities can accelerate the development of research infrastructure. Expanding research funding and incentivizing private investment in clinical trials can boost the country’s capacity to attract and conduct cutting-edge research.

Additionally, investing in educational programs and professional training for healthcare professionals involved in research can enhance expertise and foster a culture of excellence in clinical research practices. Moreover, engaging with patient communities and increasing public awareness about clinical trials can promote participation, leading to more diverse and representative study populations.


Brazil’s clinical research infrastructure continues to evolve, positioning the country as a prominent player in the global clinical research landscape. With a robust regulatory framework, renowned research institutions, and a diverse patient population, Brazil holds immense potential for advancing medical knowledge and improving patient care.

By addressing existing challenges and leveraging the opportunities available, Brazil can further strengthen its clinical research infrastructure. Streamlining regulatory processes, reducing administrative burdens, and enhancing transparency can facilitate faster trial approvals and attract more sponsors and researchers to the country.

Additionally, increasing research funding and incentivizing private investment will provide the necessary resources to support a thriving research ecosystem.

Clinical Research Infrastructure in Brazil

Source: Duke Clinical Research Institute

Clinical Research Infrastructure in Brazil

Cohortias the CRO of LATAM

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Research Infrastructure in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Research Infrastructure in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Research Infrastructure in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Research Infrastructure in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Research Infrastructure in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Research Infrastructure in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Research Infrastructure in Brazil

The Cohortias Team

Clinical Research Infrastructure in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Research Infrastructure in Brazil

Network & Partnerships